Cite
Brain-Derived Neurotrophic Factor rs6265 polymorphism is associated with severe cancer-related fatigue and neuropathic pain in female cancer survivors.
MLA
Goto, Taichi, et al. “Brain-Derived Neurotrophic Factor Rs6265 Polymorphism Is Associated with Severe Cancer-Related Fatigue and Neuropathic Pain in Female Cancer Survivors.” Journal of Cancer Survivorship : Research and Practice, vol. 18, no. 6, Dec. 2024, pp. 1851–60. EBSCOhost, https://doi.org/10.1007/s11764-023-01426-w.
APA
Goto, T., Von Ah, D., Li, X., Xiang, L., Kwiat, C., Nguyen, C., Hsiao, C.-P., & Saligan, L. N. (2024). Brain-Derived Neurotrophic Factor rs6265 polymorphism is associated with severe cancer-related fatigue and neuropathic pain in female cancer survivors. Journal of Cancer Survivorship : Research and Practice, 18(6), 1851–1860. https://doi.org/10.1007/s11764-023-01426-w
Chicago
Goto, Taichi, Diane Von Ah, Xiaobai Li, Lichen Xiang, Catherine Kwiat, Christopher Nguyen, Chao-Pin Hsiao, and Leorey N Saligan. 2024. “Brain-Derived Neurotrophic Factor Rs6265 Polymorphism Is Associated with Severe Cancer-Related Fatigue and Neuropathic Pain in Female Cancer Survivors.” Journal of Cancer Survivorship : Research and Practice 18 (6): 1851–60. doi:10.1007/s11764-023-01426-w.